Vetherapy
PrivateLast Round
Accelerator
Jan 11, 2018
Total Funding Raised
$250,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Vetherapy is a biotechnology company that develops cell therapies and regenerative products for veterinary clinical application.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vetherapy Comparables
Compare Vetherapy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medrego | 88% | |
| Animal Cell Therapies, Inc. | 85% | |
| eQcell Inc. | 83% |
Vetherapy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jan 11, 2018 |
Vetherapy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| SOSV | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 343% MoM, from 51 to 226.
- Jan 11, 2018
$250K round led by IndieBio
Vetherapy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vetherapy's valuation, stock price, and market status.
Is Vetherapy a public or private company?
Vetherapy is a private company.
What is the current stock price of Vetherapy?
Vetherapy is a private company, so its shares have no public market price. Caplight tracks Vetherapy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vetherapy worth (valuation)?
Valuation information for Vetherapy is not publicly available.
Can I buy Vetherapy stock?
Vetherapy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vetherapy's last funding round?
Vetherapy's most recent funding round was Accelerator on January 11, 2018.
Who are the main investors in Vetherapy?
Key investors in Vetherapy include European Union's Horizon Research and Innovation program, SOSV.
Will Vetherapy IPO soon?
No public IPO plans have been announced for Vetherapy.
How can I track Vetherapy secondary market activity?
Caplight tracks bids, offers, and trades in Vetherapy's shares on secondary markets.